Stocks · Health care · Pharmaceutical Preparations

Milestone Pharmaceuticals Inc.

MIST Clue Score21
Quebec, Canada Fiscal year ends December CIK 0001408443 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Joseph Oliveto
26 Jan 2026
President and CEO
Sold after exercise
34,523
$1.93
$66.63K
Amit Hasija
26 Jan 2026
CFO & EVP of Corp. Development
Sold after exercise
12,245
$1.93
$23.63K
Lorenz Muller
26 Jan 2026
Chief Commercial Officer
Sold after exercise
11,180
$1.93
$21.58K
Jeffrey Edward Nelson
26 Jan 2026
Chief Operating Officer
Sold after exercise
12,245
$1.93
$23.63K
David Bharucha
26 Jan 2026
Chief Medical Officer
Sold after exercise
12,245
$1.93
$23.63K

What was left out

Form 4 filings counted 127
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 5
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 9,914,269
Sales filed before the plan box existed 4
History held since 9 May 2019